Paul Saladino

And so there's an interesting field of research now about how do these microRNAs, which is different than messenger RNA, these microRNAs probably provide a blueprint for our cells and especially the cells of the corresponding organ that might help

repair when our organs are damaged so this is the really fascinating premise around eating organs and there's a lot of research about this from germany from the 1950s and 60s that my team found but there is evidence in animal models that when you provide either an intravenous injection of an organ or you provide like you put a little piece of liver on an embryo that's developing

repair when our organs are damaged so this is the really fascinating premise around eating organs and there's a lot of research about this from germany from the 1950s and 60s that my team found but there is evidence in animal models that when you provide either an intravenous injection of an organ or you provide like you put a little piece of liver on an embryo that's developing

repair when our organs are damaged so this is the really fascinating premise around eating organs and there's a lot of research about this from germany from the 1950s and 60s that my team found but there is evidence in animal models that when you provide either an intravenous injection of an organ or you provide like you put a little piece of liver on an embryo that's developing

the corresponding organ gets bigger. And you can give an injection of radiolabeled liver to an animal, and you see the radioactivity accumulate in this corresponding organ. So there's something going on here. The idea that organs could support the corresponding organ is really exciting, because you think about people who have...

the corresponding organ gets bigger. And you can give an injection of radiolabeled liver to an animal, and you see the radioactivity accumulate in this corresponding organ. So there's something going on here. The idea that organs could support the corresponding organ is really exciting, because you think about people who have...

the corresponding organ gets bigger. And you can give an injection of radiolabeled liver to an animal, and you see the radioactivity accumulate in this corresponding organ. So there's something going on here. The idea that organs could support the corresponding organ is really exciting, because you think about people who have...

you know, low testosterone or erectile dysfunction or women that have PCOS, which is a hormonal issue for women, or dementia. And organ therapy, I think, is something that I really hope that we can do more research on this and really show the potential of benefit to people that we've never thought about in Western medicine. It's something that happens in these indigenous tribes.

you know, low testosterone or erectile dysfunction or women that have PCOS, which is a hormonal issue for women, or dementia. And organ therapy, I think, is something that I really hope that we can do more research on this and really show the potential of benefit to people that we've never thought about in Western medicine. It's something that happens in these indigenous tribes.

you know, low testosterone or erectile dysfunction or women that have PCOS, which is a hormonal issue for women, or dementia. And organ therapy, I think, is something that I really hope that we can do more research on this and really show the potential of benefit to people that we've never thought about in Western medicine. It's something that happens in these indigenous tribes.

People often eat the corresponding organ, but we've lost this knowledge historically as humans.

People often eat the corresponding organ, but we've lost this knowledge historically as humans.

People often eat the corresponding organ, but we've lost this knowledge historically as humans.

I think that most research today is funded by pharma. And we can talk about the NIH and how many researchers at the National Institutes of Health have ties to pharma. I believe it's over 8,000. And the majority of research that's taught in medical school, the majority of research that comes out of the NIH is funded by pharma.

I think that most research today is funded by pharma. And we can talk about the NIH and how many researchers at the National Institutes of Health have ties to pharma. I believe it's over 8,000. And the majority of research that's taught in medical school, the majority of research that comes out of the NIH is funded by pharma.

I think that most research today is funded by pharma. And we can talk about the NIH and how many researchers at the National Institutes of Health have ties to pharma. I believe it's over 8,000. And the majority of research that's taught in medical school, the majority of research that comes out of the NIH is funded by pharma.

This gets back to the FDA, the Food and Drug Administration, and the USDA. And so who benefits, right? There's no liver lobby to talk to Congress, and there's no one to fund these studies.

This gets back to the FDA, the Food and Drug Administration, and the USDA. And so who benefits, right? There's no liver lobby to talk to Congress, and there's no one to fund these studies.

This gets back to the FDA, the Food and Drug Administration, and the USDA. And so who benefits, right? There's no liver lobby to talk to Congress, and there's no one to fund these studies.

This company, Heart and Soil, and the nonprofit that I built will hopefully be funding some studies to try and ask these questions and get some more interesting answers in 2024 relative to the 1950 and 1960 studies. These are not the studies that have been done. There hasn't been a lot of good nutritional research done in the last 100 years.